Active Not RecruitingACTRN12623000838617
Official study titleAn open label study to investigate the safety and feasibility of delivering 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy to patients with posttraumatic stress disorder
This study is no longer accepting new participants.
In AustraliaPTSDInterventional studyAges 18–70
- Countries
- Australia
- Sponsor
- Emyria Ltd
CompletedNCT04566601
What is this study about?Researchers compared BI 1358894 and placebo, tracking side effects to assess safety in people with borderline personality difficulties.
This study has finished and is no longer accepting participants.
In AustraliaPersonality disordersMedication studyAges 18–65
- Countries
- Australia, United States, France, + 12 others
- Sponsor
- Boehringer Ingelheim
CompletedNCT04521478
What is this study about?Researchers compared BI 1358894, placebo and Quetiapine to find out how the approaches affected depression symptoms in people with depression.
This study has finished and is no longer accepting participants.
In AustraliaDepressionMedication studyAges 18–65
- Countries
- Australia, United States, France, + 11 others
- Sponsor
- Boehringer Ingelheim
CompletedACTRN12621001079831
Official study titleExamining the efficacy of a telehealth intervention targeting addictive overeating in Australian adults: a randomised controlled trial.
This study has finished and is no longer accepting participants.
Remote / onlineAddictionInterventional studyAges 18–85
- Countries
- Australia
- Sponsor
- University of Newcastle
CompletedACTRN12619001671156
Official study titleThe LifeBuoy App: A randomised controlled trial of a mHealth intervention to help young people manage suicidal thoughts
This study has finished and is no longer accepting participants.
Remote / onlineSuicidalityInterventional studyAges 16–25
- Countries
- Australia
- Sponsor
- University of New South Wales
WithdrawnACTRN12614000121662
Official study titleA trial of targeted repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of auditory hallucinations in schizophrenia
This study was withdrawn before enrollment.
In AustraliaSchizophreniaInterventional studyAges 18–75
- Countries
- Australia
- Sponsor
- Professor Paul Fitzgerald
CompletedACTRN12625000662460
Official study titleA Randomized, Open-label, Single Dose, Crossover Trial to Assess the Effects of Food on the Pharmacokinetics of 10 mg Emestedastat Tablet in Healthy Adult Participants
This study has finished and is no longer accepting participants.
In AustraliaDepressionInterventional studyAges 18–65
- Countries
- Australia
- Sponsor
- Actinogen Medical Ltd
CompletedACTRN12616001529437
Official study titleA Two-Arm, Open-Label, Multi-Location, Single Center Study of the Craving Profile of the Nicotine Replacement Therapy Chrono Quit Smoking Solution (CQSS2; 21 mg) versus NiQuitin (registered trademark) Patch (21 mg) for Smoking Cessation in Treatment Seeking Subjects
This study has finished and is no longer accepting participants.
In AustraliaAddictionInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- Chrono Therapeutics Australia PTY LTD
CompletedACTRN12618000274279
Official study titleA visual training program to remediate perceptual abnormalities in body dysmorphic disorder: A novel intervention trial
This study has finished and is no longer accepting participants.
In AustraliaBody dysmorphic disorderInterventional studyAges 18–65
- Countries
- Australia
- Sponsor
- Swinburne University of Technology